(Q57251850)

12

Johannes Hebebrand

0 references

Peter Lichtner

9

Peter Lichtner

0 references

Kerstin Koberwitz

7

Kerstin Koberwitz

0 references

Nguyen Thi Thuy Trang

5

Thuy Trang Nguyen

0 references

Günter Brönner

4

Günter Brönner

0 references

Susann Friedel

6

Susann Friedel

0 references

Helmut Schäfer

11

Helmut Schäfer

0 references

Anne-Kathrin Wermter

3

Anne-Kathrin Wermter

0 references

Timo D. Müller

1

Timo Dirk Müller

0 references

Kathrin Reichwald

2

Kathrin Reichwald

0 references

author name string

Stefan Engeli

8

0 references

Anke Hinney

Molecular Genetics and Metabolism

13

0 references

publication date

April 2007

0 references

published in

0 references

volume

90

0 references

issue

4

0 references

page(s)

429-434

0 references

cites work

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Activation of the peripheral endocannabinoid system in human obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Endocannabinoid control of food intake and energy balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

CB1 cannabinoid receptor-mediated modulation of food intake in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Leptin-regulated endocannabinoids are involved in maintaining food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Food for thought: endocannabinoid modulation of lipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Identification and characterisation of a novel splice variant of the human CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Linkage disequilibrium in the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

β3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

An efficient procedure for genotyping single nucleotide polymorphisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Several Mutations in the Melanocortin-4 Receptor Gene Including a Nonsense and a Frameshift Mutation Associated with Dominantly Inherited Obesity in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

A test for linkage and association in general pedigrees: the pedigree disequilibrium test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Role of the endocannabinoid system in the development of tolerance to alcohol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Cannabinoids reduce symptoms of Tourette’s syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.002